Reappraisal of ischemic heart disease: fundamental role of coronary microvascular dysfunction in the pathogenesis of angina pectoris

JC Kaski, F Crea, BJ Gersh, PG Camici - Circulation, 2018 - Am Heart Assoc
In recent years, it has become apparent that coronary microvascular dysfunction plays a
pivotal pathogenic role in angina pectoris. Functional and structural mechanisms can affect …

Galectin-3: one molecule for an alphabet of diseases, from A to Z

S Sciacchitano, L Lavra, A Morgante, A Ulivieri… - International journal of …, 2018 - mdpi.com
Galectin-3 (Gal-3) regulates basic cellular functions such as cell–cell and cell–matrix
interactions, growth, proliferation, differentiation, and inflammation. It is not surprising …

Coronary microvascular dysfunction: an update

F Crea, PG Camici, CN Bairey Merz - European heart journal, 2014 - academic.oup.com
Many patients undergoing coronary angiography because of chest pain syndromes,
believed to be indicative of obstructive atherosclerosis of the epicardial coronary arteries …

Assessment and pathophysiology of microvascular disease: recent progress and clinical implications

S Masi, D Rizzoni, S Taddei, RJ Widmer… - European heart …, 2021 - academic.oup.com
The development of novel, non-invasive techniques and standardization of protocols to
assess microvascular dysfunction have elucidated the key role of microvascular changes in …

Primary coronary microvascular dysfunction: clinical presentation, pathophysiology, and management

GA Lanza, F Crea - Circulation, 2010 - Am Heart Assoc
Myocardial ischemia is usually caused by abnormalities of epicardial coronary arteries. In
the past 30 years, however, several studies have shown that abnormalities in coronary …

Determinants of long-term clinical outcomes in patients with angina but without obstructive coronary artery disease: a systematic review and meta-analysis

F Radico, M Zimarino, F Fulgenzi, F Ricci… - European heart …, 2018 - academic.oup.com
Aims The long-term prognosis of angina in patients without obstructive coronary artery
disease (CAD) is uncertain. To assess the incidence of long-term adverse outcomes in such …

Coronary microvascular dysfunction in diabetes mellitus

A Kibel, K Selthofer-Relatic… - Journal of …, 2017 - journals.sagepub.com
The significance, mechanisms and consequences of coronary microvascular dysfunction
associated with diabetes mellitus are topics into which we have insufficient insight at this …

Effects of ivabradine and ranolazine in patients with microvascular angina pectoris

A Villano, A Di Franco, R Nerla, A Sestito… - The American journal of …, 2013 - Elsevier
Patients with microvascular angina (MVA) often have persistence of symptoms despite full
classical anti-ischemic therapy. In this study, we assessed the effect of ivabradine and …

Long-term follow-up in patients with stable angina and unobstructed coronary arteries undergoing intracoronary acetylcholine testing

A Seitz, J Gardezy, G Pirozzolo, S Probst… - Cardiovascular …, 2020 - jacc.org
Objectives The aim of this study was to investigate the prognosis of a large cohort of patients
with stable angina and unobstructed coronaries undergoing acetylcholine spasm testing …

Ranolazine: a contemporary review

E Rayner‐Hartley, T Sedlak - Journal of the American Heart …, 2016 - Am Heart Assoc
Ranolazine, a piperazine derivative sold under the trade name Ranexa, is a well-tolerated
medication that selectively inhibits the late sodium current. Additionally, ranolazine has …